Abalone Bio is an early stage biotech start-up that develops antibody drugs for the treatment of diseases.
Business Model:
Revenue: $0
Employees: 1-10
Address:
City: Richmond
State: California
Zip:
Country: United States
Abalone Bio is an early stage biotech start-up that develops antibody drugs for the treatment of diseases. The company uses libraries of yeast cells expressing billions of antibody variants to grow specific antibodies that can activate or inhibit a drug target, and also uses gene sequencing, machine learning, and synthetic biology to make recombinant protein versions of its antibodies and confirm their efficacy in human cell assays, allowing treatment of rare diseases with unique modes of action. Abalone Bio was founded in 2017 and is headquartered in Richmond, California.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 2/2019 | Grant | 1 | $1.1M |
National Science Foundation National Science Foundation |
1/2022 | Seed Round | 1 | - |
Asymmetry Ventures Asymmetry Ventures |
12/2017 | Grant | 1 | $225k |
National Science Foundation National Science Foundation |
3/2020 | Seed Round | 5 | $150k |
Erik Peterson Harmonix Fund Milad Alucozai Pioneer Fund Y Combinator Erik Peterson Harmonix Fund Milad Alucozai Pioneer Fund Y Combinator |
1/2022 | Seed Round | 1 | - |
Asymmetry Ventures Asymmetry Ventures |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|